We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mercia Asset Management Plc | LSE:MERC | London | Ordinary Share | GB00BSL71W47 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -1.69% | 35.00 | 34.00 | 36.00 | 35.00 | 35.00 | 35.00 | 591,797 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 25.88M | 2.84M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/4/2020 10:46 | Pinky, someone happy to mop up the sales. Large trade again today. Same Friday Looks very interesting imv | mr.oz | |
06/4/2020 10:37 | When the sona rns comes this will bag a few times | jimduggen | |
06/4/2020 09:37 | Native antigen also working with SONA SONA just go a 2million testkit order SONA price up over 2000% from the lows | stockhunters | |
06/4/2020 09:09 | There is a weakness here as previous actions haven't shown management have investors towards very top of priority list. | p1nkfish | |
06/4/2020 09:08 | Market doesn't trust management, perhaps? | p1nkfish | |
06/4/2020 08:56 | strange action ERGO doubled its cap by £100million on covid announcement MERC back to flat on a significant covid announcement, owns 30% in both companies | stockhunters | |
03/4/2020 08:57 | Responding to Mercia's announcement yesterday, Merc has some very interesting reagent/diagnostics companies in their portfolio. Is anyone else sensing opportunity based on what the government said yesterday regarding building a new British diagnostic industry? The corona-virus pandemic has exposed not just our vulnerability, but the vulnerabilities of every country. In our case the UK is too dependent on a globalised diagnostic and clinical network. As far as the UK is concerned we need to be able to secure our access to vital diagnostic reagents and kits and if we can’t, we need some way of manufacturing them ourselves from scratch very quickly. UK diagnostic companies with at least some UK footprint appear well placed, not to mention the larger UK non-diagnostic players (e.g. pharmaceutical) are being encouraged to get actively involved in the space, and buying in new expertise and technology might be a consequence. The corona-virus highlights an important fact, that medical care is not complete without effective diagnostics.....diag So, in any regard, reagents and diagnostics will come to the fore in terms of priority. | wan | |
02/4/2020 22:29 | And more so | mr.oz | |
02/4/2020 19:44 | Will bag and more if these 2 companies get the antigen test out in mass | jimduggen | |
02/4/2020 08:34 | The obvious advantages aside this development is a major boost for the status of Mercia and will boost investment in current and future funds. | pavey ark | |
02/4/2020 07:54 | Mcap to big for a potential bagger and it holds only 30% from the companies making the tests | costax1654x | |
02/4/2020 07:38 | Well there is the Coronavirus update today | tole | |
28/3/2020 18:20 | Just dont expect management to place shareholders front and centre and do watch out for repricing of options. | p1nkfish | |
28/3/2020 15:57 | I just checked and found you posted 13 times yesterday, now that's an alarm signal for me. The post today did very little to encourage me to engage here so I think I'll continue with my own research. For what it's worth I have moved on from :- "Management out to make as much for themselves as they can".....(shock horror ....surely not ?!) As we appear to post here to warn and guide others may I suggest that any potential investors takes a close look at the Merc direct investment portfolio ....what an I saying ...you don't need me or anyone else to encourage, warn or guide you. | pavey ark | |
28/3/2020 14:28 | I'm in the money here but clear you dont want to here the plain truth. Management change would accelerate this. Just look at the history of what they have done. More moaners and whingers needed so people entering do so knowing the truth. | p1nkfish | |
28/3/2020 13:10 | Then stay well clear of this share and give the whining a miss !! | pavey ark | |
28/3/2020 09:47 | First of all thanks for pointing that there was an Edison upgrade and yes these reports do favour the company paying for the research. What is helpful from the Edison reports is the hard fact produced that cannot be fudged. Any suggestions, assumptions, predictions are clearly marked and any grown up investor can use them as they see fit. Not long ago you people were going into fits of rage over the £30m raised at 25p now that is conveniently ignored as is the cash they have. Any difficulties this company has is to be found in every company in the country and I would suggest the the problems are greater in the vast majority of these companies. I do realise that this gives people the opportunity to get aboard their old bandwagon, if they ever got off, but the repeated attempts to put Mercia down in the current exceptional circumstances does look rather silly and petty. Silly and petty to me but I've been wrong before. As always under these circumstances "cash is king" and if Mercia is in trouble then so are the vast majority of companies AND THE BANKS!! For general info: the placing didn't bother me as I had a small holding at c. 30p but bought many more below 25p esp during the Woodford situation....you pays your money and takes your chance!! | pavey ark | |
27/3/2020 08:51 | Would agree and market is demanding proof even without this virus. Sci Warehouse exit was very poor. Exit at £ multiples of investment £ is the #1 measurement of management here and so far "where's the beef". | p1nkfish | |
27/3/2020 08:39 | Edison note out - Rose tinted glasses - Suspect current price about correct unless world heading into depression - More than 50% chance of wide U rather than sharp V so increased risk (imo) of increased number of investee companies failing = Govt cash useful crutch but no substitute for customer demand | pugugly | |
20/3/2020 08:26 | I am not a particular fan of the management either, well not at this juncture anyway, but I couldn't resist topping up yesterday. | wan | |
19/3/2020 14:49 | In the sense the portfolio companies address markets with demand and do so in a way that offers them a most vs others -yes. Management -no. Liquidity of.portfolio - no. Credit risk, portfolio companies -no. Regional bias - yes. | p1nkfish | |
19/3/2020 14:24 | Three main problems here * Cut in bankrate - So massive reduction in margins * Fall in value of AUM reduced income * Most of investee companies are small and will probably have minimal cash reserves to cushion against CORVID lock down. Can anyone see any value here? | pugugly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions